儿童和青少年的心理多药性和相关因素
Mutlu Muhammed Özbek1, Ekin Atay2, Doğa Sevinçok3
1Department of Child and Adolescent Psychiatry, Yalova University, Faculty of Medicine, Yalova, Türkiye.
Psychiatry investigation
|August 21, 2025
概括
儿童和青少年精神病患者有行为障碍,年龄较大和并发症诊断更有可能接受多药性治疗. 了解这些因素是减少药物使用的关键.
科学领域:
- 儿童和青少年精神病学
- 临床心理学
- 心理药理学
背景情况:
- 多药在儿童和青少年精神病学中很常见,但影响其使用的因素需要进一步调查.
- 了解与多药学相关的临床特征对于优化治疗策略至关重要.
研究的目的:
- 检查不同年龄组的儿童和青少年精神病诊所患者的临床特征.
- 在临床样本中确定多药性及其相关因素的流行率.
主要方法:
- 用完整数据对569名患者的病历进行了回顾性分析.
- 基于DSM-5标准的精神病诊断.
- 收集的数据包括年龄,性别,教育,精神病诊断和治疗.
主要成果:
- 在多药店使用者中,易怒更为常见;在非多药店使用者中,家庭问题更为常见.
- 行为障碍诊断,年龄增长和精神病相关性与多药性相关.
- 行为障碍 (OR=11.08),年龄 (OR=1.14) 和并发症 (OR=116.87) 强烈预测多药性.
结论:
- 行为障碍,年龄和并发性精神病诊断显著增加了儿童精神病患者多药症的风险.
- 识别导致多种药物的因素对于减少该群体中不必要的药物使用至关重要.
相关概念视频
Drug Therapy
97
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
97
Psychosis: Goals of Pharmacotherapy
209
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
209
Psychosis and Antipsychotic Drugs: Overview
454
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
454
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
296
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
296
Factors Affecting Drug Response: Overview
2.4K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
947
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
947


